GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Artivion Inc (FRA:CYL) » Definitions » Cyclically Adjusted PS Ratio

Artivion (FRA:CYL) Cyclically Adjusted PS Ratio : 2.61 (As of Apr. 29, 2025)


View and export this data going back to . Start your Free Trial

What is Artivion Cyclically Adjusted PS Ratio?

As of today (2025-04-29), Artivion's current share price is €20.80. Artivion's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was €7.98. Artivion's Cyclically Adjusted PS Ratio for today is 2.61.

The historical rank and industry rank for Artivion's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:CYL' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.38   Med: 3.35   Max: 6.63
Current: 2.88

During the past years, Artivion's highest Cyclically Adjusted PS Ratio was 6.63. The lowest was 1.38. And the median was 3.35.

FRA:CYL's Cyclically Adjusted PS Ratio is ranked worse than
57.87% of 470 companies
in the Medical Devices & Instruments industry
Industry Median: 2.175 vs FRA:CYL: 2.88

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Artivion's adjusted revenue per share data for the three months ended in Dec. 2024 was €2.219. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €7.98 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Artivion Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Artivion's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artivion Cyclically Adjusted PS Ratio Chart

Artivion Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.88 3.02 1.65 2.29 3.47

Artivion Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.29 2.65 3.17 3.25 3.47

Competitive Comparison of Artivion's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Artivion's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artivion's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Artivion's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Artivion's Cyclically Adjusted PS Ratio falls into.


;
;

Artivion Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Artivion's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=20.80/7.98
=2.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artivion's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Artivion's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=2.219/133.1571*133.1571
=2.219

Current CPI (Dec. 2024) = 133.1571.

Artivion Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 1.136 99.621 1.518
201506 1.142 100.684 1.510
201509 1.144 100.392 1.517
201512 1.274 99.792 1.700
201603 1.216 100.470 1.612
201606 1.279 101.688 1.675
201609 1.216 101.861 1.590
201612 1.271 101.863 1.661
201703 1.254 102.862 1.623
201706 1.259 103.349 1.622
201709 1.084 104.136 1.386
201712 1.272 104.011 1.628
201803 1.390 105.290 1.758
201806 1.574 106.317 1.971
201809 1.472 106.507 1.840
201812 1.626 105.998 2.043
201903 1.624 107.251 2.016
201906 1.664 108.070 2.050
201909 1.654 108.329 2.033
201912 1.656 108.420 2.034
202003 1.608 108.902 1.966
202006 1.273 108.767 1.558
202009 1.459 109.815 1.769
202012 1.445 109.897 1.751
202103 1.541 111.754 1.836
202106 1.623 114.631 1.885
202109 1.381 115.734 1.589
202112 1.794 117.630 2.031
202203 1.759 121.301 1.931
202206 1.899 125.017 2.023
202209 1.935 125.227 2.058
202212 1.868 125.222 1.986
202303 1.923 127.348 2.011
202306 2.021 128.729 2.091
202309 2.014 129.860 2.065
202312 2.100 129.419 2.161
202403 1.872 131.776 1.892
202406 2.185 132.554 2.195
202409 2.062 133.029 2.064
202412 2.219 133.157 2.219

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Artivion  (FRA:CYL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Artivion Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Artivion's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Artivion Business Description

Traded in Other Exchanges
Address
1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Artivion Headlines

No Headlines